2 FTSE 100 dividend stocks I’d buy today

With such a large number of companies cancelling or cutting dividends, income has been hard to come by. These dividend stocks should help fill the hole.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

It’s been a pretty dismal year for income investors. A total of 445 companies listed on the London Stock Exchange have either cancelled, cut or suspended dividend payments. This has included previous big dividend-payers such as BT Group and Royal Dutch Shell. Nonetheless, some FTSE 100 companies have remained committed to payments, and these two dividend stocks are my top picks.

A pharmaceuticals giant

GlaxoSmithKline (LSE: GSK) is one of the leading healthcare companies in the world. The group operates in three different business segments, including pharmaceuticals, vaccines and consumer healthcare. And while this is seen as a fairly defensive sector, especially during a pandemic, the giant group hasn’t been immune to the impacts of coronavirus. For example, turnover in the vaccines sector fell by 29% in the second quarter as regular vaccination programmes were delayed. And adjusted operating profits were 19% lower than the previous year. This has seen its share price fall by 20% this year, leaving the stock looking very cheap indeed.

But it’s the firm’s status as a dividend stock that grabs my interest. While there has been limited dividend growth over the years, the company has consistently made dividend payments of 80p a year. At its currently depressed price, this equates to a very strong yield of 5.6%. With dividend cover of around 1.6, the payout is also well-covered by earnings, and I can’t see a cut coming any time soon. Consequently, I’d buy Glaxo shares at their current valuation.

A dividend stock yielding over 8%

Often a very high dividend yield can indicate limited growth in a company. A dividend cut may also be very likely at some point in the near future. Even so, in the case of Legal & General (LSE: LGEN), I think neither of these apply.

For example, the firm has seen significant growth in the past few years, with 2019 earnings rising 12% from the year before. The first-half trading update was also positive, and operating profits totalled £946m. This was only a 6% decrease compared to the same period in 2019, showing a strong performance in a difficult economic environment. I believe that the insurer should be able to continue growing profits over the next few years, thanks to its status as the UK’s leader in bulk annuities, life insurance and other retirement products. An ageing population should help to drive this growth.

Strong profits also allowed the group to announce an interim dividend of 4.93p. This corresponds to a total year payout of 17.57p, or a very high yield of 8.6%. The fact that the dividend was higher than the previous year further demonstrates LGEN’s standing as an excellent dividend stock. I reckon investors can expect further increases in the forthcoming years, and as such, I’d happily buy this stock today.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Stuart Blair owns shares in Legal & General and Royal Dutch Shell. The Motley Fool UK has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

£17,000 in savings? Here’s how I’d target a weighty passive income

Funnelling any spare savings towards building a passive income is certainly a smart idea, but how to find the right…

Read more »

Investing Articles

Why is this FTSE 250 giant up 35% in two weeks?

Seeing a share price soaring can often be a reason to be cautious, but I still think there's a lot…

Read more »

Light bulb with growing tree.
Investing Articles

Is there still time to snap up this ex-penny stock in May?

A penny stock no more but a promising low-cap company nonetheless. Our writer examines the growth prospects of this sustainable…

Read more »

Close-up of British bank notes
Investing Articles

Here’s how I’d target a £1,890 second income by investing £35 a week

Christopher Ruane explains how, for a fiver a day, he'd aim to build a second income of almost £1,900 in…

Read more »

Dividend Shares

£5k in savings? Here’s how I’d try to turn it into £414 of monthly passive income

Jon Smith explains how he'd use both dividend and growth shares to help him take a lump sum of £5k…

Read more »

Fans of Warren Buffett taking his photo
Investing Articles

Warren Buffett’s sitting on $189bn in cash. What’s this telling us?

Legendary stock market investor Warren Buffett's currently sitting on a cash pile bigger than most FTSE 100 companies. Is this…

Read more »

Typical street lined with terraced houses and parked cars
Dividend Shares

Here’s how much income I’d make if I invested all my ISA in Taylor Wimpey shares

Jon Smith explains why researching Taylor Wimpey shares could be a good move, based on historical dividend payments and the…

Read more »

Value Shares

Why Marks and Spencer could be one of the UK’s best value stocks right now

With a low valuation and a rising dividend payout, Marks and Spencer could be a great value stock to consider,…

Read more »